Chuvash polycythemia: genes and variants
Chuvash polycythemia is linked to 1 analyzed protein (VHL). 116 DNA variants are known to cause it; 455 more are uncertain, and 9 of those already look disease-causing on computable evidence.
Last updated 2026-09-30. Research information, not medical advice.
Genes linked to Chuvash polycythemia
VHL: von Hippel-Lindau disease tumor suppressor
It targets hydroxylated HIF-alpha proteins for ubiquitin-mediated degradation when oxygen is sufficient, keeping hypoxia-response programs suppressed. Loss of function stabilizes HIF signaling and causes von Hippel-Lindau tumor-predisposition syndrome while also driving most clear-cell renal carcinomas.
116 disease-causing and 455 uncertain variants in VHL are linked to Chuvash polycythemia.
Where Chuvash polycythemia variants cluster
- VHL Involved in binding to CCT complex (positions 100–155): 48 of 116 disease-causing changes, 1.6× more than its size predicts.
- VHL Interaction with Elongin BC complex (positions 157–166): 14 of 116 disease-causing changes, 2.6× more than its size predicts.
Known disease-causing variants in Chuvash polycythemia
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| VHL R82L | 82 | Disease-causing (★★) | |
| VHL P86S | 86 | Disease-causing (★★) | |
| VHL G93V | 93 | Disease-causing (★★) | |
| VHL G93S | 93 | Disease-causing (★★) | |
| VHL Y98H | 98 | Disease-causing (★★) | |
| VHL R107H | 107 | Involved in binding to CCT complex | Disease-causing (★★) |
| VHL S111R | 111 | Involved in binding to CCT complex | Disease-causing (★★) |
| VHL Y112C | 112 | Involved in binding to CCT complex | Disease-causing (★★) |
| VHL D121G | 121 | Involved in binding to CCT complex | Disease-causing (★★) |
| VHL P154S | 154 | Involved in binding to CCT complex | Disease-causing (★★) |
| VHL R161Q | 161 | Interaction with Elongin BC complex | Disease-causing (★★) |
| VHL R167W | 167 | Disease-causing (★★) | |
| VHL Y175C | 175 | Disease-causing (★★) | |
| VHL S65L | 65 | Disease-causing (★★) | |
| VHL N78T | 78 | Disease-causing (★★) | |
| VHL N78D | 78 | Disease-causing (★★) | |
| VHL S80I | 80 | Disease-causing (★★) | |
| VHL S80N | 80 | Disease-causing (★★) | |
| VHL S80G | 80 | Disease-causing (★★) | |
| VHL S80R | 80 | Disease-causing (★★) | |
| VHL V84M | 84 | Disease-causing (★★) | |
| VHL P86R | 86 | Disease-causing (★★) | |
| VHL P86A | 86 | Disease-causing (★★) | |
| VHL W88R | 88 | Disease-causing (★★) | |
| VHL G93R | 93 | Disease-causing (★★) | |
| VHL G93D | 93 | Disease-causing (★★) | |
| VHL Y98C | 98 | Disease-causing (★★) | |
| VHL Y98S | 98 | Disease-causing (★★) | |
| VHL R107P | 107 | Involved in binding to CCT complex | Disease-causing (★★) |
| VHL S111G | 111 | Involved in binding to CCT complex | Disease-causing (★★) |
| VHL Y112H | 112 | Involved in binding to CCT complex | Disease-causing (★★) |
| VHL Y112N | 112 | Involved in binding to CCT complex | Disease-causing (★★) |
| VHL Y112S | 112 | Involved in binding to CCT complex | Disease-causing (★★) |
| VHL G114R | 114 | Involved in binding to CCT complex | Disease-causing (★★) |
| VHL G114S | 114 | Involved in binding to CCT complex | Disease-causing (★★) |
| VHL H115Q | 115 | Involved in binding to CCT complex | Disease-causing (★★) |
| VHL H115R | 115 | Involved in binding to CCT complex | Disease-causing (★★) |
| VHL N131K | 131 | Involved in binding to CCT complex | Disease-causing (★★) |
| VHL N131Y | 131 | Involved in binding to CCT complex | Disease-causing (★★) |
| VHL V155M | 155 | Involved in binding to CCT complex | Disease-causing (★★) |
| VHL Q164H | 164 | Interaction with Elongin BC complex | Disease-causing (★★) |
| VHL V84L | 84 | Disease-causing (★★) | |
| VHL L101P | 101 | Involved in binding to CCT complex | Disease-causing (★★) |
| VHL R107G | 107 | Involved in binding to CCT complex | Disease-causing (★★) |
| VHL S111N | 111 | Involved in binding to CCT complex | Disease-causing (★★) |
| VHL N131S | 131 | Involved in binding to CCT complex | Disease-causing (★★) |
| VHL A149S | 149 | Involved in binding to CCT complex | Disease-causing (★★) |
| VHL P154L | 154 | Involved in binding to CCT complex | Disease-causing (★★) |
| VHL L158V | 158 | Interaction with Elongin BC complex | Disease-causing (★★) |
| VHL L158P | 158 | Interaction with Elongin BC complex | Disease-causing (★★) |
| VHL R161G | 161 | Interaction with Elongin BC complex | Disease-causing (★★) |
| VHL C162W | 162 | Interaction with Elongin BC complex | Disease-causing (★★) |
| VHL C162R | 162 | Interaction with Elongin BC complex | Disease-causing (★★) |
| VHL C162F | 162 | Interaction with Elongin BC complex | Disease-causing (★★) |
| VHL L163R | 163 | Interaction with Elongin BC complex | Disease-causing (★★) |
| VHL L163F | 163 | Interaction with Elongin BC complex | Disease-causing (★★) |
| VHL L163P | 163 | Interaction with Elongin BC complex | Disease-causing (★★) |
| VHL Q164R | 164 | Interaction with Elongin BC complex | Disease-causing (★★) |
| VHL R167G | 167 | Disease-causing (★★) | |
| VHL R167P | 167 | Disease-causing (★★) |
Showing 60 of 116.
Uncertain variants in Chuvash polycythemia that look disease-causing
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| VHL R200W | 200 | Conflicting reports (★) | +6: 3 other pathogenic changes within 3 positions; R200L at the same position is pathogenic; REVEL 0.867 | |
| VHL V130I | 130 | Involved in binding to CCT complex | Conflicting reports (★) | +6: 6 other pathogenic changes within 3 positions; V130L at the same position is pathogenic; REVEL 0.824 |
| VHL R64H | 64 | Conflicting reports (★) | +6: 4 other pathogenic changes within 3 positions; R64S at the same position is pathogenic; REVEL 0.798 | |
| VHL I151V | 151 | Involved in binding to CCT complex | Conflicting reports (★) | +6: 9 other pathogenic changes within 3 positions; I151T at the same position is pathogenic; REVEL 0.780 |
| VHL R82C | 82 | Uncertain (★★) | +6: 9 other pathogenic changes within 3 positions; R82G at the same position is pathogenic; REVEL 0.944 | |
| VHL V155A | 155 | Involved in binding to CCT complex | Uncertain (★★) | +6: 10 other pathogenic changes within 3 positions; V155G at the same position is pathogenic; REVEL 0.850 |
| VHL F76C | 76 | Uncertain (★★) | +6: 6 other pathogenic changes within 3 positions; F76Y at the same position is pathogenic; REVEL 0.917 | |
| VHL F76L | 76 | Uncertain (★★) | +6: 6 other pathogenic changes within 3 positions; F76Y at the same position is pathogenic; REVEL 0.893 | |
| VHL F136L | 136 | Involved in binding to CCT complex | Uncertain (★★) | +6: 2 other pathogenic changes within 3 positions; F136V at the same position is pathogenic; REVEL 0.863 |
Which prediction tools work for Chuvash polycythemia
How often each tool ranks a disease-causing variant above a harmless one (AUROC × 100).
- CATVariant: 90 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 88 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 88 out of 100
- PolyPhen-2: 87 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 85 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- phyloP: 77 out of 100
- SIFT: 72 out of 100
Same protein, different disease
- Von Hippel-Lindau syndrome is also caused by VHL variants; they fall in the same places as the Chuvash polycythemia variants (147 disease-causing).
- Pheochromocytoma is also caused by VHL variants; they fall in the same places as the Chuvash polycythemia variants (4 disease-causing).
Diseases related to Chuvash polycythemia
- Von Hippel-Lindau syndrome, also linked to VHL
- Pheochromocytoma, also linked to VHL
- Inherited phaeochromocytoma and paraganglioma excluding NF1, also linked to VHL
- Nonpapillary renal cell carcinoma, also linked to VHL
- Renal cell carcinoma, also linked to VHL
Frequently asked questions
Which genes are linked to Chuvash polycythemia?
In CATVariant, Chuvash polycythemia is linked to 1 analyzed protein: VHL (von Hippel-Lindau disease tumor suppressor).
How many genetic variants are linked to Chuvash polycythemia?
576 variants: 116 are classified as disease-causing (pathogenic or likely pathogenic) in ClinVar and 455 are of uncertain significance or have conflicting reports.
Which uncertain variants in Chuvash polycythemia look disease-causing?
9 uncertain variants reach the likely-pathogenic range of the ACMG/AMP points scale on computable evidence, for example VHL R200W, VHL V130I, VHL R64H, VHL I151V and VHL R82C. These are leads for expert review, not diagnoses.
Which variant effect predictor works best for Chuvash polycythemia?
Among tools not trained on clinical labels, CADD separates this disease's known disease-causing variants from harmless ones best (AUROC 0.88, based on 29 disease-causing and 16 harmless variants).
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from the latest public CATVariant analysis of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center